Microbiota Restoration in Recurrent C. difficile (C. diff. ) and COVID-19
This activity is intended for gastroenterologists, infectious disease specialists, and other clinicians who care for patients at risk of serious infection.
Activity Purpose: While the incidence of multiply recurrent C. difficile continues to rise, FMT has emerged as a means to break the cycle. Amid the current COVID-19 pandemic, clinicians should be aware of the additional safety concerns that have arisen. Expert faculty will discuss approaches to FMT including sourcing and screening of donor stool, which requires heightened safety measures during the COVID-19 pandemic. This activity is the first in a series of two educational activities that address the latest data on treating patients who experience rCDI.
Please click on the following link to be redirected to the activity
In joint efforts with the C Diff Foundation Advocates and organizations dedicated in preventing and treating life-threatening Clostridioides difficile (C. diff., C. difficile) infections, we express our gratitude and congratulate the State of Arizona, Arkansas, Idaho, Michigan, Minnesota, New Mexico, Pennsylvania, West Virginia, Wisconsin, to name a few, to date for declaring November “Clostridioides difficile (C. diff., C. difficile) Awareness Month.
The Proclamations approved serve to heighten awareness of the impact this disease has on patients across the United States. The infection, which has been labeled an urgent national health threat by the Centers for Disease Control (CDC), results in 500,000 infections each year and is directly responsible for approximately 29,000 patients who died within 30 days of the initial diagnosis of C. difficile. Of those, about 15,000 deaths were estimated to be directly attributable to C. difficile infections.
An excerpt from USA Today article published in 2012: Deaths and illnesses are much higher than reports have shown. In March, the CDC said in a report that the C difficile infection kills 14,000 people a year. But that estimate is based on death certificates, which often don’t list the infection when patients die from complications, such as kidney failure. Hospital billing data collected by the federal Agency for Healthcare Research and Quality shows that more than 9% of C. diff-related hospitalizations end in death — nearly five times the rate for other hospital stays. That adds up to more than 30,000 fatalities among the 347,000 C. diff hospitalizations in 2010. Thousands of patients are treated in nursing homes, clinics and doctors’ offices.
“We’re talking in the range of close to 500,000 total cases a year,” says Cliff McDonald, a C. diff expert, and senior science adviser in the CDC’s Division of Healthcare Quality Promotion. And annual fatalities “may well be … as high as 30,000.”
* AHRQ News and Numbers provides statistical highlights on the use and cost of health services and health insurance in the United States.
In the USA: Nearly half a million Americans suffer from Clostridium difficile (C. diff.) infections in a single year according to a study released February 25, 2015, by the Centers for
Not only in November, but every day of the year it is our time to make a difference! Most patients and their families, until their diagnosis, are not familiar with this infectious disease. When they tell their friends and family, their friends and family have never heard of a C. difficile (Clostridium difficile, C. diff., CDI) infection before.
Sometimes, even when they are told by their doctors of this diagnosis, the doctors can be largely unfamiliar with the impact of this infection and the treatments readily available. This is astonishing. Why? Because a C. diff. infection impacts individuals differently than it did decades ago. The re-occurrence rate is greater today than it was in previous years. C.difficile infections are not only acquired by a hospital stay but can be community-acquired. It is a global diagnosis and this infection is not isolated in the senior population, however; seniors remain in the higher risk category of acquiring this infection.
FACT: About a C. diff. infection — Over 41 individuals lose their life to a Clostridioides difficile infection in the United States of America alone each day — C. difficile has no boundaries — It can be acquired by anyone – at any location and at any age.
Every year we work together to change the level of C. difficile awareness worldwide. Every year we make a difference. Every day of every year we share information through education and advocacy for patients and continue to raise awareness of Clostridioides difficile infection (C. diff., C. difficile, CDI) prevention, treatments, clinical trials, and environmental safety — further than the day before.
“None of us can do this alone – All of us can do this together.”
Clostridioides difficile (C. diff. C. difficile, CDI) has had an immeasurable impact on our families, in our communities, in our countries. It is a leading Healthcare-associated infection (HAI) yet awareness of Clostridioides difficile remains quite low among the general public worldwide.
Help us change this. Contact us and join us TODAY!
Draft a letter to your State Governor requesting a Proclamation for November dedicated for promoting Clostridium difficile Infection Awareness.
Share the C Diff Foundation brochure (request your copies by e-mail) A great guide to explain details about a C. diff. infection and data on C. diff. prevention, treatments, and environmental safety available.
The Clinical Trials Page showcases Clostridium difficile prevention and treatment clinical trials available and research-driven results.
Share C.diff. Global Community Support session information which is FREE and available across the USA and accessible from 57 countries to learn more about a C. diff. infection, Nutrition, and to speak with health care providers and fellow-C.diff. survivors to gain knowledge and have questions answered.
Social Media Involvement
Please join us and share YOUR story. Use these November Awareness campaign hashtags to spread awareness for November Is Clostridioides difficile (Clostridium difficile, C.diff., C.difficile, CDI) Infection Awareness Month.
To obtain printed literature to share with your family, friends, colleagues, in your community and with your health care providers — along with a “November Is C. diff. Awareness Month” Magnet, please contact the C Diff Foundation’s Main Office (727) 205-3922 or email your request: firstname.lastname@example.org
How do Antibiotics cause C. diff.? The antibiotics cause a disruption in the normal intestinal flora which leads to an overgrowth of C. difficile bacteria in the colon. Leading antibiotics are known to disrupt the normal intestinal flora.
As far back as November 2012, the CDC started sharing a public announcement regarding antibiotic use: Colds and many ear and sinus infections are caused by viruses, not bacteria. Taking antibiotics to treat a “virus” can make those drugs less effective when you and your family really need them. Limiting the usage of antibiotics will also help limit new cases of CDI.
*Always discuss the symptoms and medications with the treating Physician/Healthcare Provider.
Your participation makes a BIG difference around the globe.
Improving Care Transitions in Clostridioides Difficile Infection
Thursday, November 14, 2019 at 2:00pm Eastern/11:00am Pacific
Intended Audience: Physicians, Nurse Practitioners, Physician Assistants, Nurses, Pharmacists and Case Managers
Overview: With advances in Clostridioides difficile infection (CDI) treatment and recurrence prevention, and recently updated IDSA/SHEA guidelines, remarkable potential exists to improve CDI patient outcomes through effective interventions at critical transition points.
Join CDI experts Sahil Khanna, MD, MBBS, and Kevin Garey, PharmD, MS, FASHP, for an interactive webinar highlighting core concepts and strategies from the CDI Transitions of Care (TOC) Pathway. The CDI TOC Pathway was developed in partnership with the National Transitions of Care Coalition (NTOCC) to arm system leaders and CDI care teams with essential interventions and tools to ensure safe and effective TOCs for patients with CDI across care settings.
Overview of the Clostridioides difficile infection (CDI) Transitions of Care Pathway
How Do Ineffective Care Transitions Impact Patients with CDI?
III. Assessing CDI Risk and Implementing Diagnostic Stewardship
Advances in the Treatment of Primary and Recurrent CDI
Engaging CDI Patients and Caregivers in Effective and Safe Care Transitions
Sahil Khanna, MBBS
Kevin W Garey, PharmD, MS, FASHP
Michael R Stinchon, Jr, RPH
Offering 1.0 hour of ACCME, AAPA, AANP, ACPE, ANCC, and CCM credit.
Click on the graphic below to be directed to the webinar on
November 14th at 2:00 EST
Supporter statement: This activity is provided by PRIME Education. There is no fee to participate. This activity is supported by an educational grant from Merck & Co. Inc.
With its fresh Spring mornings and lovely long evenings – not to mention an extra long weekend – it’s no wonder that May is the official National Walking Month. Whether you prefer leisurely strolls or challenging hikes, our four park surroundings have a walk for everyone to raise awareness of C.diff., walk for a cause in all locations. Lace up your walking shoes and venture out to Milton A. Votee Park, Teaneck, N.J., Charlestown Township Park, Phoenixville, PA.,Sims Park, New Port Richey, FL., on Saturday, May 18th to experience one of these 3 C.diff. Awareness 2k walks.
The USA events will take place on Saturday, May 18, 2019 from 8 a.m. – 12 p.m.
Dr. Martha Cloakie, PhD will be leading the walk in Leicester, U.K. on Friday, May 17, 2019.
All registered awareness walkers will receive t-shirts, giveaways, and educational material while introducing the communities to the resources available. C.diff. infections are one of the leading healthcare-associated infections facing local communities.
Proceeds from the events will benefit the C Diff Foundation’s mission educating and advocating for C.difficile infection prevention, treatments, clinical trials, environmental safety, sepsis, and antibiotic awareness worldwide.
According to the Centers for Disease Control and Prevention (CDC), a Clostridioides difficile infection (C.difficile), (formally known as Clostridium difficile) “has become the most common microbial cause of healthcare-associated infections in U.S. hospitals and costs up to $4.8 billion each year in excess health care costs for acute care facilities alone.”
Statistics provided by the CDC suggest that C. difficile cause nearly 500,000 infections in patients in the U.S. annually. In one study noted by the CDC, among infected patients, nearly 29,000 died within 30 days of being diagnosed, and more than half of those deaths (15,000) were directly attributable to a C. difficile infection.
We sincerely thank Vedanta Biosciences, Inc. for being the Diamond Sponsor of the 3rd Annual Global C.diff. Awareness 2K Walks. Vedanta Biosciences, Inc. is dedicated to finding treatments for patients with serious infections and immune diseases. Vedanta develops medicines made of consortia of bacterial strains which are selected to effect robust and durable changes in a patient’s gut microbiota. In contrast to fecal transplants or administration of fecal fractions, Vedanta’s medicines are pure, uniform compositions of bacteria manufactured from clonal cell banks, bypassing the need to rely on direct sourcing of fecal donor material of inconsistent composition. Vedanta is currently enrolling patients with recurrent C. difficile infections (CDI) in its CONSORTIUM study to evaluate VE303, an investigational treatment for CDI.
Our gratitude to all of the sponsors for their support and partnering with the C Diff Foundation in raising C. diff. awareness worldwide:
If you have any questions, please contact one of our staff members at
(727) – 205 – 3922 or e-mail: email@example.com
We look forward to walking with you on May 18th!
Follow Us On Twitter: #CdiffWalks2019